Vimarsana
Biggest News Aggregation in the World

Retina Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Retina Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Retina Division Today - Breaking & Trending Today

Case Challenges in nAMD and DME Management: Achieving Durable Response - Vimarsana News

Case Challenges in nAMD and DME Management: Achieving Durable Response

Healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Source: healio.com
Dr Darius Moshfeghi Outlines the Impact of Delayed Treatment in ROP - Vimarsana News

Dr Darius Moshfeghi Outlines the Impact of Delayed Treatment in ROP

Retinopathy of prematurity (ROP) that occurs in preterm babies can progress fast, which requires quick decisions early about treatment, explained Darius M. Moshfeghi, MD, chief, Retina Division, and professor at the Horngren Family Vitreoretinal Center, Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine.

Source: ajmc.com
Early study shows cones in retinal degenerati - Vimarsana News

Early study shows cones in retinal degenerati

New UCLA research in mice suggests that “dormant” cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.

LumiThera Inc.: LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data - Vimarsana News

LumiThera Inc.: LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE III, multi-center clinical trial

LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry Age-Related Macular Degeneration - Vimarsana News

LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry Age-Related Macular Degeneration

/PRNewswire/ -- LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today...